AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2014
Mar 4, 2014
29755_dirs_2014-03-04_ab4d36d7-de59-4290-9e05-5fe80f3f90ae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-28
Reporting Person: CHASE WILLIAM J (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-28 | Common stock, $0.01 par value | F | 9873 | $51.91 | Disposed | 184016 | Direct |
| 2014-03-03 | Common stock, $0.01 par value | S | 2448 | $50.1910 | Disposed | 181568 | Direct |
| 2014-03-03 | Common stock, $0.01 par value | S | 1400 | $50.1940 | Disposed | 180168 | Direct |
| 2014-03-03 | Common stock, $0.01 par value | S | 100 | $51.1950 | Disposed | 180068 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 501 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4